NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 7534 | SCILLIROSIDIN, GLYCOSIDE | 0.0268790882218883 | 0.12601451 |
NSC 277184 | 1H-Inden-1-one, 6-[2-(dimethylamino)ethoxy]-2,3-dihydro-2-[(1-methyl-5-nitro-1H-imidazol-2-yl)methylene]-, sulfate (1:1) | 0.0284896579188828 | 0.14325268 |
NSC 693247 | Null | 0.0284896579188828 | 0.15663972 |
NSC 745678 | Null | 0.0284896579188828 | -0.030917616 |
NSC 755295 | 2-(1-(3-chlorophenylsulfonyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide | 0.0284896579188828 | 0.33572208 |
NSC 756248 | GW513184X | 0.0284896579188828 | 0.12803916 |
NSC 105014 | Cladribine | 0.0285477013888565 | 0.28591129 |
NSC 113497 | 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) | 0.0285477013888565 | 0.25125126 |
NSC 126228 | Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) | 0.0285477013888565 | 0.065392855 |
NSC 294961 | 5-Bromo-3-(2-oxo-2-phenylethylidene)- 1,3-dihydroindol-2-one | 0.0285477013888568 | 0.14197318 |